Thyroid Radiofrequency Ablation of Thyroid Nodules: A 2017 Preview Comments
Richard Guttler MD,FACE,ECNU
Clinical Professor of Medicine Keck/USC school of Medicine
Director, Santa Monica Thyroid Center, Santa Monica Ca 90404
Member, American Association of Clinical Endocrinologist’s task force on the introduction of thyroid radiofrequency ablation RFA of thyroid nodules to the United States.
Radiofrequency Ablation has been reported in various tumors including liver or kidney tumors but not for thyroid in the USA. However thyroid RFA has been reported to be a safe and efficient treatment option in managing symptomatic cold thyroid nodules or hyperfunctioning thyroid nodules in other countries. Cosmetic and symptoms have been shown to be significantly improved both in the short and long terms after RFA.
Hyperfunctioning thyroid nodules, RFA is indicated when surgery or radioiodine are not indicated or patient refuse surgery or radio-iodine. Thyroid function improves with decreased need for antithyroid medications.
RFA complication rate is relatively low compared to surgery.